Thymulin Protocol: Complete Cycling & Dosing Guide

Overview

Thymulin is a zinc-dependent nonapeptide thymic hormone with established roles in T-cell development and immune function. Unlike anabolic compounds, thymulin operates as an immunomodulatory peptide—its primary application centers on supporting immune resilience, particularly in contexts of immune decline, zinc deficiency, or compromised T-cell function.

The fundamental principle governing thymulin efficacy is zinc availability. Without bound zinc, thymulin remains biologically inactive. This makes concurrent zinc status monitoring or supplementation essential to any thymulin protocol.

Current research shows thymulin effectiveness in:

• Supporting T-cell differentiation and maturation
• Modulating pro-inflammatory cytokines (TNF-α, IL-1β reduction)
• Enhancing regulatory T-cell activity for immune tolerance
• Restoring thymic hormone activity in zinc-deficient states

Thymulin carries no established efficacy for fat loss, muscle growth, cognitive enhancement, mood improvement, or sleep quality. Its profile is narrow but clinically relevant for immune support and potential longevity applications in aging populations.

Standard Protocol

Injection Route (Subcutaneous or Intramuscular)

Baseline Dosing:

• 20–40 mcg per injection
• 3 injections per week (Monday/Wednesday/Friday schedule, or equivalent spacing)
• Cycle duration: 8–12 weeks on, followed by 4–6 week break

Frequency Options:

• Conservative: 20 mcg × 3 weekly
• Standard: 30 mcg × 3 weekly
• Aggressive: 40 mcg × 3 weekly

Most users begin at 20–30 mcg to establish tolerance. Escalation to 40 mcg occurs only after 2–3 weeks of side-effect assessment.

Intranasal Route

Baseline Dosing:

• 100–200 mcg once daily
• Cycle duration: 8–12 weeks on, followed by 4–6 week break

Intranasal delivery avoids injection site irritation but produces variable absorption. Nasal mucosal inflammation may develop with daily dosing, necessitating occasional off-days (2 days per week without administration).

Recommended intranasal schedule:

• Monday through Friday dosing, with Saturday/Sunday off
• Alternate: 5 days on, 2 days off

Zinc Concurrent Supplementation

Thymulin activity depends entirely on zinc binding. If baseline zinc status is unknown, concurrent zinc supplementation is prudent:

• Zinc gluconate or picolinate: 15–30 mg elemental zinc daily
• Begin zinc 3–5 days before thymulin initiation
• Continue throughout the entire thymulin cycle
• Maintain zinc supplementation during off-weeks to preserve baseline immune function

Monitor for copper imbalance with extended high-dose zinc (>50 mg/day may suppress copper absorption over months). Standard doses of 15–30 mg rarely cause issues.

Goal-Specific Protocols

Protocol A: Immune Support & General Wellness

Target: Healthy individuals seeking to optimize T-cell function and immune resilience.

Duration: 12 weeks on, 6 weeks off

Dosing (Injection):

• Weeks 1–2: 20 mcg × 3 weekly
• Weeks 3–12: 30 mcg × 3 weekly

Dosing (Intranasal):

• Weeks 1–12: 150 mcg daily, 5 days on / 2 days off

Zinc Support:

• 20 mg elemental zinc daily throughout cycle and break periods

Assessment: Baseline and week-12 serum thymulin levels (optional but informative). Monitor for respiratory infections, cold severity/duration, and general energy baseline.

Protocol B: Age-Related Immune Decline (Immunosenescence Support)

Target: Individuals 60+ seeking to counteract age-related thymic involution and T-cell dysfunction.

Duration: 12 weeks on, 8 weeks off, repeat

Dosing (Injection):

• Weeks 1–4: 20 mcg × 3 weekly
• Weeks 5–12: 30 mcg × 3 weekly

Dosing (Intranasal):

• Weeks 1–12: 150–200 mcg daily, 5 days on / 2 days off

Zinc Support:

• 25 mg elemental zinc daily year-round

Extended Protocol: Repeat the 12-week cycle with 8-week breaks indefinitely. Aging populations show sustained immune benefit with cycled dosing.

Additional Support:

• Concurrent vitamin D status optimization (serum 25-OH vitamin D: 40–60 ng/mL)
• Adequate protein intake (1.2–1.5 g/kg body weight daily)

Protocol C: Post-Infection Recovery & Immune Restoration

Target: Recovery from significant infection, immunosuppressive illness, or post-transplant immune reconstitution.

Duration: 8 weeks on, 4 weeks off

Dosing (Injection):

• Weeks 1–2: 20 mcg × 3 weekly
• Weeks 3–8: 30–40 mcg × 3 weekly

Dosing (Intranasal):

• Weeks 1–8: 150–200 mcg daily, 5 days on / 2 days off

Zinc Support:

• 30 mg elemental zinc daily

CD4 Monitoring (if applicable):

• Baseline, week 4, and week 8 CD4 count assessment
• Continue thymulin cycles until CD4 recovery plateaus or reaches target range

How to Administer Step-by-Step

Injectable Thymulin Preparation

Reconstitution (Lyophilized Powder):

1. Gather supplies: Sterile syringe (1 mL), sterile needle (25–27 gauge for injection; 18–20 gauge for reconstitution), sterile bacteriostatic saline (0.9% NaCl with benzyl alcohol), alcohol prep pad, vial of lyophilized thymulin.

2. Calculate reconstitution: Most research-grade thymulin vials contain 5–10 mg. Reconstitute with 1–2 mL bacteriostatic saline to achieve a concentration of 5–10 mg/mL, depending on vial contents. Confirm concentration from supplier documentation.

3. Clean the vial cap with an alcohol prep pad. Allow to dry completely (15–20 seconds).

4. Draw reconstitution volume into the syringe using the larger reconstitution needle. Insert needle into the vial at an angle, inject saline slowly along the vial wall (not directly onto the powder), and allow the solution to sit for 2–3 minutes without agitation.

5. Gentle mixing: Rotate the vial slowly between your palms for 30–60 seconds until the powder is fully dissolved. Do not shake vigorously, as this degrades peptide structure.

6. Verify clarity: The solution should be clear and colorless. If cloudiness persists after 5 minutes, discard the vial.

7. Store reconstituted solution: Refrigerate at 2–8°C. Reconstituted thymulin is stable for approximately 14–21 days under refrigeration.

Dose Withdrawal:

1. Insert a fresh 25–27 gauge needle into the reconstituted vial. Draw back the plunger slightly to equalize pressure, then draw the required volume (e.g., 3–4 mL for a 30 mcg dose from a 10 mg/mL concentration).

2. Replace the needle with a fresh sterile needle before injection.

Subcutaneous Injection Technique

1. Select injection site: Lower abdomen, 2 inches lateral to the umbilicus, or outer thigh. Rotate sites with each injection to avoid lipohypertrophy.

2. Cleanse the area with an alcohol prep pad using a circular motion, starting at the center and expanding outward. Allow skin to air-dry completely.

3. Pinch the skin gently between thumb and forefinger to create a small fold.

4. Insert the needle at a 45–90 degree angle (45 degrees for smaller individuals, 90 degrees for those with adequate subcutaneous tissue). Insert the needle fully until only the hub remains visible.

5. Aspirate gently: Pull back the plunger slightly. If blood is withdrawn, remove the needle and choose a different site. If no blood appears, proceed.

6. Inject the solution slowly over 3–5 seconds.

7. Withdraw the needle and apply gentle pressure with a clean pad for 10 seconds if minor bleeding occurs.

8. Do not massage the injection site, as this increases systemic absorption and may increase side effects.

Intranasal Administration

1. Prepare the solution: Thymulin for intranasal use is typically supplied as a prepared liquid at 100–200 mcg/mL concentration. Do not reconstitute powder for intranasal delivery without specific supplier guidance.

2. Clear nasal passages: Gently blow your nose to remove mucus and debris. Saline rinse is optional but helpful.

3. Prime the nasal spray device (if applicable) by pressing the pump 2–3 times until a fine mist appears.

4. Tilt your head slightly forward (approximately 10 degrees). Do not tilt the head backward, as this allows drainage into the throat rather than absorption through nasal mucosa.

5. Insert the applicator gently into one nostril, sealing the opening around it.

6. Press the pump or spray device once while inhaling gently through your nose. Do not sniff forcefully immediately after administration.

7. Exhale gently through your mouth. Repeat in the opposite nostril if the protocol calls for bilateral administration (e.g., 100 mcg per nostril = 200 mcg total).

8. Do not blow your nose for 15–30 minutes after administration to allow mucosal absorption.

Cycle Example (Week-by-Week Schedule)

12-Week Immune Support Cycle with 6-Week Break

Week 1–2: Loading Phase

• Injection: 20 mcg Monday, Wednesday, Friday
• Zinc: 20 mg daily
• Assessment: Baseline energy, general symptom log

Week 3–12: Maintenance Phase

• Injection: 30 mcg Monday, Wednesday, Friday
• Zinc: 20 mg daily
• Week 4: Note any changes in infection frequency or respiratory health
• Week 8: Informal immune assessment (any colds, infections?)
• Week 12: Final injection; discontinue thymulin

Week 13–18: Off-Cycle (6 Weeks)

• Zinc: Continue 20 mg daily
• Allow immune system to stabilize at baseline
• No thymulin dosing

Week 19 onward: Repeat the 12-week cycle if desired

Alternative Intranasal 8-Week Cycle

Week 1–2: Introduction Phase

• Intranasal: 150 mcg daily, Monday–Friday (2 days off per week)
• Zinc: 25 mg daily
• Observation: Note nasal irritation, general tolerance

Week 3–8: Maintenance Phase

• Intranasal: 150 mcg daily, Monday–Friday
• Zinc: 25 mg daily
• Week 6: Assess for nasal congestion or irritation; if present, reduce frequency to Monday–Thursday (3 days on, 4 days off)

Week 9 onward: Off-Cycle (4 Weeks)

• Zinc only: 20 mg daily
• No intranasal thymulin

What to Expect (Timeline of Effects)

Injection Route Timeline

Days 1–3 (First Injection)

• Possible mild injection site redness or warmth (resolves within 4–6 hours)
• Some users report transient fatigue or mild malaise (typically resolves within 24 hours)

Week 1–2

• Minimal systemic effects; site irritation may persist if injection technique needs refinement
• No dramatic subjective changes expected

Week 3–4

• Most injection site reactions resolve
• Subjective energy baseline established; some report subtle improvement in "immune resilience" (harder to quantify)
• Possible slight reduction in cold/infection frequency (if applicable)

Week 5–8

• Peak thymulin activity in serum (if measured)
• Immune parameters (CD4 count, thymulin activity) may normalize if baseline was depressed
• Respiratory infections may decrease in frequency or severity in susceptible populations

Week 9–12

• Immune effects plateau; continued maintenance
• Off-cycle begins; expect return to baseline immune parameters within 2–4 weeks

Intranasal Route Timeline

Days 1–3

• Possible mild nasal irritation, congestion, or rhinorrhea (usually transient)
• No systemic effects expected

Week 1–2

• Nasal irritation may persist; if moderate or severe, reduce frequency to 3 days weekly and reassess
• Systemic effects absent or negligible

Week 3–4

• Nasal tolerance improves in most users
• Subtle immune effects (if any) begin to emerge

Week 5–8

• Continued nasal tolerance maintenance
• Immune parameters stabilize; no dramatic subjective changes typical

General Expectations Across Both Routes

Thymulin is not a "feel-good" compound. Users should not expect energy surges, mood elevation, strength gains, or fat loss. Expected outcomes are subtle and immunological in nature:

• Reduced frequency or severity of upper respiratory infections (if baseline was elevated)
• Improved wound healing (limited evidence; animal studies showed impairment)
• Normalized thymulin activity in zinc-deficient individuals
• Potential CD4 recovery in post-infection or immunocompromised populations

The absence of dramatic subjective changes does not indicate the compound is ineffective; thymulin's benefits are largely detectable only via immune markers (CD4 count, thymulin serum levels, cytokine profiles).

Common Protocol Mistakes

Mistake 1: Omitting Zinc Supplementation

Error: Administering thymulin without concurrent zinc support.

Consequence: Thymulin requires zinc binding for biological activity. Without adequate zinc status, the peptide is inert. A substantial portion of the protocol's benefit is lost.

Correction: Include 20–30 mg elemental zinc daily throughout the cycle and breaks.

Mistake 2: Aggressive Dosing Without Assessment

Error: Beginning at 40 mcg three times weekly without a 2-week tolerance assessment at 20 mcg.

Consequence: Unnecessary injection site reactions, transient malaise, or rare hypersensitivity responses.

Correction: Always start at 20 mcg and escalate to 30–40 mcg only after 2–3 weeks of uneventful dosing.

Mistake 3: Neglecting Injection Technique

Error: Injecting intravenously, intramuscularly without training, or into areas of previous lipohypertrophy.

Consequence: Altered pharmacokinetics, hematoma formation, or accelerated tissue changes.

Correction: Strictly adhere to subcutaneous administration. Rotate injection sites systematically (lower abdomen, upper thigh, upper arm). Never reuse needles.

Mistake 4: Continuous Dosing Without Breaks

Error: Running thymulin continuously without off-cycles.

Consequence: Potential immune dysregulation or tolerance; receptor downregulation may reduce responsiveness over extended periods.

Correction: Follow the prescribed 4–6 week off-cycles after 8–12 weeks on. This allows the immune system to normalize and preserves long-term sensitivity.

Mistake 5: Over-Expectation of Non-Immune Benefits

Error: Expecting thymulin to improve cognition, mood, energy, fat loss, or muscle growth.

Consequence: Disappointment and protocol abandonment; misattribution of unrelated changes to thymulin.

Correction: Use thymulin exclusively for immune support. If cognition or mood improvement is desired, employ evidence-backed alternatives (e.g., sleep optimization, cognitive training for cognition; exercise, light therapy for mood).

Mistake 6: Intranasal Dosing Without Frequency Breaks

Error: Daily intranasal thymulin dosing without periodic off-days.

Consequence: Cumulative nasal irritation, congestion, rhinitis medicamentosa risk.

Correction: Limit intranasal dosing to 5 days per week (Monday–Friday, off weekends) or use the 3-on / 4-off pattern if irritation emerges.

How to Stack with Other Compounds

Zinc Supplementation